Clinical Outcomes Following Transcatheter Tricuspid Valve Replacement – A Meta-Analysis
TTVR is a feasible and safe intervention for patients with severe TR, providing significant functional improvement and TR reduction. Robust, longer-term randomized controlled trials with standardized outcome reporting and clinical endpoints are urgently needed to define durable clinical benefit and guide optimal device selection for patients with severe TR.
Authors
- Serge C. Harb (ORCID: https://orcid.org/0000-0002-7442-4928)
- Radwan Alkhatib (ORCID: https://orcid.org/0000-0002-5210-7817)
- Grant William Reed (ORCID: https://orcid.org/0000-0001-8234-3135)
- Akiva Rosenzveig (ORCID: https://orcid.org/0000-0001-6757-8841)
- Taha Hatab (ORCID: https://orcid.org/0009-0006-6184-8314)
- Saeid Mirzai (ORCID: https://orcid.org/0000-0002-2579-4965)
- Samir Kapadia (ORCID: https://orcid.org/0000-0002-0026-3391)
- Rishi Puri (ORCID: https://orcid.org/0000-0001-8849-7426)
- Osamah Badwan (ORCID: https://orcid.org/0000-0001-9899-3220)
- Mangesh Kritya (ORCID: https://orcid.org/0000-0002-5508-5107)
- Faysal Massad
- Amar Krishnaswamy
Institutions
- Houston Methodist (US)
- Cleveland Clinic (US)
- Wake Forest University (US)
Publication Details
- Journal
- Structural Heart
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1016/j.shj.2025.100721
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00